Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Neuroscientists identify white matter "scaffold" of human brain

Neuroscientists identify white matter "scaffold" of human brain

Researchers identify protein that promotes growth of brain cells damaged by MS

Researchers identify protein that promotes growth of brain cells damaged by MS

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Communication for people with impaired speech: an interview with Professor Mark Hawley, Professor of Health Services Research, Director of CATCH and lead researcher for VIVOCA

Communication for people with impaired speech: an interview with Professor Mark Hawley, Professor of Health Services Research, Director of CATCH and lead researcher for VIVOCA

Researchers discover new signaling pathway that could impact treatment of autoinflammatory diseases

Researchers discover new signaling pathway that could impact treatment of autoinflammatory diseases

Study shows how pesticides may contribute to development of Parkinson's disease

Study shows how pesticides may contribute to development of Parkinson's disease

New technique helps identify shrinkage of mood-regulating brain structure in women with MS

New technique helps identify shrinkage of mood-regulating brain structure in women with MS

Comparison of cognitive tests shows SDMT effective in differentiating employment status in MS individuals

Comparison of cognitive tests shows SDMT effective in differentiating employment status in MS individuals

Biogen Idec, UCB sign agreements to commercialize treatment of MS and hemophilia in Asia

Biogen Idec, UCB sign agreements to commercialize treatment of MS and hemophilia in Asia

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

Use of smartphones and tablets to search for prescription drug information rising rapidly

Use of smartphones and tablets to search for prescription drug information rising rapidly

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

Researchers reveal role of extra thymus gland in the network of body's natural defense systems

Researchers reveal role of extra thymus gland in the network of body's natural defense systems

BRI receives grant to lead ITN for evaluating novel therapies for transplantation, allergy and autoimmune diseases

BRI receives grant to lead ITN for evaluating novel therapies for transplantation, allergy and autoimmune diseases

People with higher levels of omega-3 fatty acids may have larger brain volumes in old age

People with higher levels of omega-3 fatty acids may have larger brain volumes in old age

Researchers assess familial risks for MS using population registers, health care registries

Researchers assess familial risks for MS using population registers, health care registries

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.